Tolerability Study of Xerecept® in Pediatric Patients
Status:
Terminated
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to evaluate the safety and tolerability of Xerecept® in
children with central nervous system tumors and to identify appropriate doses of Xerecept® to
be used in subsequent pediatric clinical trials.